We examined the Oncomine database and determined that Galectin-1 expression in liver tissues was significantly higher in patients with HCC or cirrhosis than in those without HCC or cirrhosis (Figure 1E). This evidence concerns the gene LGALS1 and hepatocellular carcinoma.